EnVVeno Medical Corporation (NASDAQ:NVNO)

PRESS RELEASE

published on 03/15/2024 at 14:00, 8 months 7 days ago

enVVeno Medical to Participate in the Virtual Investor Lunch Break: The enVVeno Opportunity
enVVeno Medical to present at Virtual Investor Lunch Break on March 21, 2024, with CEO Robert Berman discussing the company's outlook and the enVVeno Opportunity

EnVVeno Medical Venous Disease Treatment Virtual Investor Lunch Break Robert Berman Bioprosthetic Solutions
BRIEF

published on 03/06/2024 at 14:45, 8 months 16 days ago

EnVVeno Medical Corporation annonce les résultats positifs de l'essai pivot VenoValve

EnVVeno Medical Insuffisance Veineuse Chronique VenoValve Approbation De La FDA Amélioration Clinique
BRIEF

published on 03/06/2024 at 14:45, 8 months 16 days ago

EnVVeno Medical Corporation Announces Positive Results from VenoValve Pivotal Trial

FDA Approval EnVVeno Medical VenoValve Chronic Venous Insufficiency Clinical Improvement
PRESS RELEASE

published on 03/06/2024 at 14:40, 8 months 16 days ago

Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve(R) Pivotal Trial to be Presented Today at the VENOUS2024 American Venous Forum Annual Meeting
enVVeno Medical presents positive topline efficacy data from the SAVVE U.S. pivotal trial for the VenoValve at the 2024 American Venous Forum Annual Meeting, showing significant clinical improvement in CVI patients

EnVVeno Medical VenoValve Clinical Improvement SAVVE Trial CVI Patients
BRIEF

published on 02/29/2024 at 22:20, 8 months 22 days ago

EnVVeno Medical publie des résultats financiers et des progrès cliniques positifs pour 2023

Résultats Financiers 2023 Essais Cliniques EnVVeno Medical VenoValve Équipement Médical
BRIEF

published on 02/29/2024 at 22:20, 8 months 22 days ago

EnVVeno Medical Reports Positive 2023 Financials and Clinical Progress

Medical Devices Clinical Trials Financial Results 2023 EnVVeno Medical VenoValve
PRESS RELEASE

published on 02/29/2024 at 22:15, 8 months 22 days ago

enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
enVVeno Medical Corporation reports $46.4 million in cash, progress towards the VenoValve U.S. pivotal trial, and financial results for 2023, anticipating value driving milestones in 2024

Financial Results Clinical Trials VenoValve EnVVeno Medical Corporation Value Driving Milestones
PRESS RELEASE

published on 02/20/2024 at 14:30, 9 months 2 days ago

Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the VENOUS2024 American Venous Forum Annual Meeting on March 6, 2024
enVVeno Medical to present topline efficacy data from VenoValve U.S. pivotal trial at 2024 AVF Annual Meeting. VenoValve aims to address severe Chronic Venous Insufficiency with innovative bioprosthetic solutions

Clinical Trial EnVVeno Medical VenoValve Chronic Venous Insufficiency AVF Annual Meeting
BRIEF

published on 02/20/2024 at 14:30, 9 months 2 days ago

Promising Results for enVVeno Medical in the Treatment of Venous Insufficiency

EnVVeno Medical VenoValve RVCSS Chronic Venous Insufficiency Venous Treatment
BRIEF

published on 02/20/2024 at 14:30, 9 months 2 days ago

Résultats prometteurs pour enVVeno Medical dans le traitement de l'insuffisance veineuse

EnVVeno Medical Insuffisance Veineuse Chronique VenoValve RVCSS Traitement Veineux

Published on 11/22/2024 at 23:55, 11 hours 26 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 11 hours 51 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 12 hours 16 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 12 hours 16 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 12 hours 51 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 17 hours 7 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 17 hours 21 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 17 hours 28 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 18 hours 26 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 19 hours 21 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 17:45, 17 hours 36 minutes ago

IMMERSION : RFA 2023/2024
Published on 11/22/2024 at 16:15, 19 hours 6 minutes ago

NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Published on 11/22/2024 at 14:35, 20 hours 46 minutes ago

Communiqué de presse Thales
Published on 11/22/2024 at 14:35, 20 hours 46 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 4 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio

View all LES ECHOS COMFI WIRE

News